Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
WuXi AppTec Co., Ltd. Class H ( (HK:2359) ) just unveiled an announcement.
WuXi AppTec Co., Ltd. announced the results of its extraordinary general meeting (EGM) held on January 22, 2025, where key resolutions were approved by shareholders. The meeting included the retirement and election of an independent non-executive director, with Mr. Xuesong Leng elected to the board. The announcement reflects WuXi AppTec’s ongoing corporate governance activities and its commitment to maintaining a strong leadership team, which is crucial for its strategic positioning in the competitive life sciences sector.
More about WuXi AppTec Co., Ltd. Class H
WuXi AppTec Co., Ltd. is a joint stock company incorporated in the People’s Republic of China. The company operates in the healthcare and life sciences industry, providing a range of services including drug discovery, development, and manufacturing.
YTD Price Performance: -1.33%
Average Trading Volume: 5,716,567
Technical Sentiment Consensus Rating: Hold
Current Market Cap: HK$168.3B
For a thorough assessment of 2359 stock, go to TipRanks’ Stock Analysis page.
